Volume 33, Issue 6, November 2023

Structural, nonclinical, and clinical features of ozoralizumab: A novel tumour necrosis factor inhibitor

• Abstract
• View article

Role of rituximab in the treatment of systemic sclerosis: A literature review

• Abstract
• View article
• Supplementary data

Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort study

• Abstract
• View article
• Supplementary data

Safety and effectiveness of tofacitinib in Korean adult patients with rheumatoid arthritis: A post-marketing surveillance study

• Abstract
• View article
• Supplementary data

Comparative analysis of low-field magnetic resonance imaging in patients with rheumatoid arthritis treated with certolizumab pegol or infliximab

• Abstract
• View article

Comparison of clinical and radiographic results of mobile-bearing total ankle arthroplasty between osteoarthritis and rheumatoid arthritis

• Abstract
• View article

Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis

• Abstract
• View article

Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody–associated vasculitis: Effectiveness and safety in the first 6 months

• Abstract
• View article
• Supplementary data

Intravenous immunoglobulin for chronic residual peripheral neuropathy in microscopic polyangiitis: A multicentre randomised double-blind trial

• Abstract
• View article
• Supplementary data

Chemoprophylaxis against Pneumocystis jirovecii pneumonia in Japanese patients with ANCA-associated vasculitis: An observational study

• Abstract
• View article
• Supplementary data

Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis

• Abstract
• View article
• Supplementary data

Clues to mortality trends and their related factors in IgG4-related disease: A Japanese single-centre retrospective study

• Abstract
• View article

Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study

• Abstract
• View article
• Supplementary data

Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis

• Abstract
• View article
• Supplementary data

Vitamin D status-associated postoperative complications in patients with hip dysplasia after periacetabular osteotomy: A case–control study

• Abstract
• View article

Predicting outcomes after total knee arthroplasty using intraoperative knee kinematics measured by navigation

• Abstract
• View article

Investigating the subchondral trabecular bone microstructure in patients with osteonecrosis of the femoral head using multi-detector row computed tomography

• Abstract
• View article

Feasibility and applicability of locomotive syndrome risk test in elderly patients who underwent total knee arthroplasty

• Abstract
• View article
• Supplementary data

Cut-off values for achieving osteoporosis treatment goals in women with rheumatoid arthritis receiving denosumab

• Extract
• View article

Associations of autoimmune bullous diseases and autoantibodies against epidermal autoantigens in patients with inflammatory myopathy

• Extract
• View article

Validating MRI and ultrasound findings to predict bone destruction in rheumatoid arthritis

• Extract
• View article